TippingPoint Biosciences
Develops novel drug discovery platform to target epigenetic targets in pediatric brain cancer
$4.5MSeed
Role not disclosedFV
Freeflow Ventures
Activity from announced rounds
Activity in this selectionHealthtech
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $14.5M 2 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
2 in this selectionVivere Oncotherapies
Vivere Oncotherapies develops cancer treatments designed to activate immune recognition and destruction of cancer cells.
$10MSeries A
Role not disclosed